NS1643 Interacts around L529 of hERG to Alter Voltage Sensor Movement on the Path to Activation  by Guo, Jiqing et al.
1400 Biophysical Journal Volume 108 March 2015 1400–1413ArticleNS1643 Interacts around L529 of hERG to Alter Voltage Sensor Movement
on the Path to ActivationJiqing Guo,1 Yen May Cheng,2 James P. Lees-Miller,1 Laura L. Perissinotti,3 TomW. Claydon,2 Christina M. Hull,2
Samrat Thouta,2 Daniel E. Roach,1 Serdar Durdagi,3 Sergei Y. Noskov,1,3,* and Henry J. Duff1,*
1Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada; 2Department of Biomedical Physiology and
Kinesiology, Molecular Cardiac Physiology Group, Simon Fraser University, Burnaby, British Columbia, Canada; and 3Centre for Molecular
Simulations, Department of Biological Sciences, University of Calgary, Calgary, Alberta, CanadaABSTRACT Activators of hERG1 such as NS1643 are being developed for congenital/acquired long QT syndrome. Previous
studies identify the neighborhood of L529 around the voltage-sensor as a putative interacting site for NS1643. With NS1643,
the V1/2 of activation of L529I (34 5 4 mV) is similar to wild-type (WT) (37 5 3 mV; P > 0.05). WT and L529I showed no
difference in the slope factor in the absence of NS1643 (8 5 0 vs. 9 5 0) but showed a difference in the presence of
NS1643 (9 5 0.3 vs. 22 5 1; P < 0.01). Voltage-clamp-fluorimetry studies also indicated that in L529I, NS1643 reduces the
voltage-sensitivity of S4movement. To further assessmechanism of NS1643 action, mutations were made in this neighborhood.
NS1643 shifts the V1/2 of activation of both K525C and K525C/L529I to hyperpolarized potentials (131 5 4 mV for K525C
and 120 5 21 mV for K525C/L529I). Both K525C and K525C/K529I had similar slope factors in the absence of NS1643
(18 5 2 vs. 34 5 5, respectively) but with NS1643, the slope factor of K525C/L529I increased from 34 5 5 to 71 5 10
(P < 0.01) whereas for K525C the slope factor did not change (18 5 2 at baseline and 16 5 2 for NS1643). At baseline,
K525R had a slope factor similar to WT (9 vs. 8) but in the presence of NS1643, the slope factor of K525R was increased to
245 4 vs. 95 0 mV for WT (P < 0.01). Molecular modeling indicates that L529I induces a kink in the S4 voltage-sensor helix,
altering a salt-bridge involving K525. Moreover, docking studies indicate that NS1643 binds to the kinked structure induced by
the mutation with a higher affinity. Combining biophysical, computational, and electrophysiological evidence, a mechanistic prin-
ciple governing the action of some activators of hERG1 channels is proposed.INTRODUCTIONWell-orchestrated opening and closing or gating of ion chan-
nels in cardiac myocytes controls cardiac electrical excita-
tion and relaxation that is directly coupled to the normal
functioning of the heart (1). A component of this mechanism
is the presence of potassium channels that shape signaling by
selective permeation of Kþ and voltage-dependent gating
(2). Previous studies of voltage-dependent gating inKþ chan-
nels have reported substitution of three nonpolar residues of
the S4 of the Shaw channel into Shaker (V369I, I372L,
S376T; ILTmotif) reproduced the voltage-dependent proper-
ties of activation of the Shaw channel (3–6). These amino-
acid substitutions were quite conservative, suggesting that
physiologically very important changes can be achieved
with rather subtle modifications of nonpolar amino acids
within the S4. Moreover, the Aldrich laboratory (5,6) pro-
vided direct evidence that the slowed activationwas achieved
by changing cooperative transitions late in the pathway to-
ward opening of the channel. Their studies suggested that
noncharged residues in the S4 could play a pivotal role inSubmitted April 24, 2014, and accepted for publication December 8, 2014.
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0006-3495/15/03/1400/14 $2.00the cooperative interactions between subunits that preceded
a final opening step. The general involvement of uncharged
residues in model systems can be extended to clinically rele-
vant human proteins such as a family of hERG1 channels.
The hERG1 gene (also referred to as KCNH2) encodes
the a-subunit of an ion channel (Kv11.1, sometimes simply
denoted as hERG1) underlying the rapid component in
the delayed rectified potassium current (IKr) in cardiac
myocytes (7). In the human heart, modulation of hERG1
currents reportedly has both therapeutic and proarrhythmic
consequences (8,9). Wang and Rasmusson (10) have
modeled the state-dependent changes in activation of
hERG1 channels. Compared to the activation of Shaker,
the activation kinetics of the ionic hERG1 current are very
slow. Gating current kinetics indicate that voltage-sensor
movements in the pathway toward activation of the hERG
channel are also slow, although components of charge that
move quickly have also been reported (10–13). In general,
voltage-sensor movements reported from fluorescence
studies mirror the movement of the majority of charge
measured using gating currents (14).
While the best-characterized feature of hERG1 is drug
interaction with its promiscuous intracavity blocking site
by a variety of drugs, a rapidly emerging strategy focuses
on channel activation by small molecules—i.e., channelhttp://dx.doi.org/10.1016/j.bpj.2014.12.055
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novel drug candidates for their ability to attenuate hERG1
function has led to an identification of compounds capable
of hERG1 current enhancement. A thorough examination
of the effects of hERG1 activators in vitro and in intact
cardiac tissue has not yet been completed. A drug-induced
increase in the time-dependent IKr rather than its tail current
could truncate the action potential and cause the short
QT syndrome similar to that of gain-of-function mutations
(16). One of the best-characterized hERG activators is
NS1643 (17,18). It shifts the voltage-dependence of activa-
tion to hyperpolarized potentials, shifts the voltage-depen-
dence of C-type inactivation to depolarized potentials, and
increases tail-current amplitude. In a 2012 study, we used
a structure-guided mutagenesis strategy to identify a num-
ber of novel amino acids that have proximity to NS1643
docked to a model of the hERG1 channel (18). One amino
acid that was identified as potentially being involved in
NS1643 binding was L529. However, the electrophysiolog-
ical responses to NS1643 for that mutation were not exam-
ined. The reported binding region in the S4 was relatively
large, spanning from L523 to V535 and from L553 toW568.
In our original article (18), radial cavities (10 A˚) were
created around a reference residue and then the reference
amino acid was iteratively shifted to examine the character-
istics of multiple radial cavities. The docking scores were
obtained for each radial cavity to identify the most likely
targets. We recognized that this approach had limitations
because of the flexibility of this domain and the homology
model itself. The L529 residue was identified as a potentially
important residue but it was not highlighted as a key residue.
Even so, we identified other residues (18) that were important
determinants of pharmacologic response to NS1643. This
study is based on the observation that L529 is equivalent to
the hydrophobic isoleucine amino acid of the ILT domain
(Table S1 in the Supporting Material) described by the
Aldrich laboratory (5,6). Thus, a different experimental
approach is being used to refine our understanding of the
importance of residues in the large and flexible NS1643
binding domain of hERG1. It is also tempting to propose a
possible coupling between an activator binding to the chan-
nel and subsequent gating modification via perturbing coop-
erative movements of the voltage-sensor between subunits.
Accordingly, this study focuses on the impact of substitutions
of nonpolar amino acids at the L529 site in the S4 of hERG1
on the characteristic response to NS1643. We combined
biochemical, spectroscopic, electrophysiological, and theo-
retical studies to gain deeper understanding of functional
and structural factors governing activator action and its
dependence on nonpolar moieties in the S4 helix.MATERIALS AND METHODS
All animals were housed in the Animal Resource Centre of the Faculty
of Medicine, University of Calgary, or at the Alberta or Simon FraserUniversity, Burnaby, British Columbia, Canada, using protocols in accor-
dance with animal care guidelines established by the Canadian Council
on Animal Care.S4 sequences alignment
Table S1 shows the alignment of S4 sequences highlighting the ILT
sequence identified by Aldrich’s laboratory in Shaker and Shaw as it relates
to the equivalent hERG1 sequence (3–6). L529 in hERG1 appears to be
equivalent to I of the ILT motif. This is part of the rationale for creating
L529I hERG1. A second part of the rationale is that we previously reported
that L529 has proximity to NS1643 when docked to a homology model of
hERG1 (18).Structural model of hERG1
Our model of the S1–S6 domains of hERG1 channel has been previously
reported in Subbotina et al. (19) and Durdagi et al. (20) and has been inde-
pendently validated by a number of laboratories (21,22). This homology
model was used to guide mutagenesis to define potential binding sites of
NS1643 to hERG1 (18). A number of putative binding sites were identified.
One of the key binding sites was the S4 domain of hERG1. In this study,
this homology model was used to help understand the potential molecular
interactions of NS1643 in the neighborhood of L529.Molecular dynamics on wild-type and
L529I hERG1
A series of molecular-dynamics (MD) simulations were performed to
test possible structural effects of L529I mutation and to refine binding
pocket for future docking studies. All MD simulations were carried out
using our previous homology models of hERG1 open and closed states
with the NAMD program (23) and the CHARMM-27/CHARMM-36
force fields for proteins, ions, and phospholipids, and the TIP3P water
model (24). All simulations were carried out at 323 K and 1 atm using
periodic boundary conditions and the NPT ensemble. Similar to
previous MD simulations of Kþ channels, the particle-mesh Ewald algo-
rithm was used for electrostatic interactions. Kþ ions at the selectivity
filter were used in the S0:S2:S4 positions according to previous studies.
Each model was embedded into the DPPC membrane bilayer using the
CHARMM-GUI membrane builder protocol. The simulation box con-
tained one protein, DPPC molecules, 3 Kþ ions, and pore water molecules
in the intracellular cavity, solvated by 0.15 M KCl aqueous salt solution.
Structures were minimized and equilibrated with gradually decreasing
harmonic constraints (see CHARMM-GUI equilibration protocol for
details) for 2 ns and then subjected to a 50-ns production run. Langevin
dynamics with very weak friction coefficient was used to keep the
temperature constant. The Langevin Nose´-Hoover method as implemented
in CHARMM 36b1 (24) was used to maintain the pressure at 1 atm.
The HELANAL module of the MDAnalysis software (25) was used to
analyze the geometry of the helices on the basis of their Ca carbons
alone. The geometry of the a-helix is characterized by computing the
local helix axes and local helix origins for four contiguous Ca atoms
(26). The softwares VMD (27) and PYMOL (28) were used to visualize
trajectories.Molecular docking
The methodology used to dock the NS1643 activator has been previously
reported in Durdagi et al. (18). Briefly, the derived chemical coordinates
of the drug were docked to the channel using GLIDE/INDUCED FIT
DOCKING programs.Biophysical Journal 108(6) 1400–1413
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The methods for site-directed mutagenesis have been previously reported in
Durdagi et al. (18). The hERG1 constructs were transfected into mamma-
lian hEK cells because their background potassium currents are small
and no dofetilide-sensitive tail current is observed in untransfected hEK
cells. For the parallel Xenopus oocyte studies, hERG1a channels were
expressed in Xenopus laevis oocytes using a pBluescript SKII expression
vector. The L520C mutation in the S3-S4 linker was used as a site for fluo-
rophore labeling of the voltage sensor, while two endogenous extracellular
cysteine residues (C445 and C449) in the S1-S2 linker were mutated to
valine to prevent background labeling (29). Mutant L529I/L520C/C445V/
C449V (henceforth called L529I L520C) constructs were generated with
conventional overlap PCR using primers synthesized by Sigma Genosys
(Oakville, Ontario, Canada) and sequenced using Eurofins MWG Operon
(Huntsville, AL). Constructs were linearized with XbaI restriction endonu-
clease and cRNA was transcribed in vitro using the mMessage mMachine
T7 Ultra cRNA transcription kit (Ambion, Austin, TX). Oocytes were pre-
pared and injected with 50 nL cRNA (at concentrations of 1–30 ng/mL) as
described in Cheng et al. (30).FIGURE 1 Slope decrease of the activation-voltage relationship for
L529I after NS1643 application. Data are recorded in transfected hEK cells.
(A and B, inset) Command protocol used to elicit the family of currents.
Family of elicited currents for WT hERG1 (top row) versus L529I (bottom
row). Mean normalized current-voltage relationships (far-right columns).
Data under control conditions (C) and in the presence of 10 mM
NS1643 (B) are compared. The n value for WT is 20 and for L529I is
25. Data are presented as mean 5 SE. Comparing V1/2 in control to that
in NS1643; the P values were 0.00056 in WT and 0.07 in L529I. For k
values, the P values were 0.08 and 0.00000009. The paired Student’s
t-test was used. For statistical analysis, see Tables 1 and 3.Electrophysiology
Transfected hEK cells were grown on glass coverslips. The coverslips were
placed in a 2-cc chamber, which was superfused at a rate of 2 mL/min at
room temperature. The whole-cell voltage-clamp methods have been previ-
ously reported in Durdagi et al. (18). The pipette solution contained KCl
10 mM, K-aspartate 110 mM, MgCl2 5 mM, Na2ATP 5 mM, EGTA
10 mM, HEPES 5 mM, and CaCl2 1 mM, corrected to pH 7.2 with KOH.
The extracellular solution contained NaCl 140 mM, KCl 5.4 mM, CaCl2
1 mM, MgCl2 1 mM, HEPES 5 mM, and glucose 5.5 mM, corrected to
pH 7.4 with NaOH. For hERG1 measurements the whole cell configuration
of the patch-clamp method was used. The series resistance measured in
the solution was <7 MU. Data were sampled at 1 kHz. The patch-clamp
protocol is shown in Fig. 1 A. The holding potential was 80 mV. All
tail currents reported from patch-clamp experiments represent dofetilide-
sensitive currents.Voltage-dependence of activation
From a holding potential of 80 mV, cells were depolarized for 2 s to a
range of voltages from –80 to þ50 mV followed by a step to 120 mV
to record the tail currents. The isochronal tail current-voltage plots were
fit to a single Boltzmann function (18):
Y
Ymax
¼ 1
1þ exp V1=2  Vm

k
: (1)
In this formulation, y (the y axis of the graph) is the normalized current for
patch-clamp recordings and conductance (two-electrode voltage-clamp) or
DF (voltage-clamp fluorimetry). V1/2 is voltage of the half-maximal activa-
tion, and k is the slope factor. Using the Boltzmann function for steady-state
activation may lead to an underestimation of the gating charge movement,
zg, during activation. Accordingly, another estimate was then used: the
limiting slope of the logarithm of the open probability when channel open-
ing is assessed near the threshold potential for channel activation. From a
holding potential of 80 mV, voltage steps were applied at 2–4 mV incre-
ments at voltages negative to the threshold potential and from threshold to
valuesþ16 mVabove the threshold values. Using this approach, the Za limit
term can be calculated using the following formula (32):
Za ¼ lim
Vm
kBT
dlnPO
dVm
: (2)Biophysical Journal 108(6) 1400–1413Envelope of tails
The activation of hERG1 channels was examined at the V1/2 potential in
hEK cells. The protocol is shown later in Fig. 4. The cells are held at
80 mV and the membrane was stepped to the V1/2 potential for various
durations. The envelope of the tail currents was fitted with a single exponen-
tial function. The activation time delay is defined as the time where the
exponential fit intersects the time axis. The data for the envelope of tails
was also fit to a power function, as follows:
I ¼ IKinf ½ð1 expðt=tÞÞn: (3)
The raw current and time data were processed with MATLAB (The
MathWorks, Natick, MA). The MATLAB NLINFIT function was used toperform the nonlinear least-squares regression. The outcome parameters
from this function were best-fit measures of t; IKinf, the maximum current
asymptotevalue; and n, the exponent.MATLABuses theNLPARCI function
to determine the 95% confidence intervals for the model parameters.
The nonlinear regression was performed using data from t ¼ 0 to the
end time, which yielded the lowest mean residual error for the model fit
(typically 0.3–0.5 s).C-type inactivation
At potentials negative to the potassium equilibrium potential, the current
deactivates very rapidly. Even at voltages of 70 to 60 mV the kinetics
of the current decay is determined by both deactivation and inactivation.
To minimize the contribution of contamination by deactivation, we assessed
the V0.3, a voltage where inactivation dominates. In our experiments, the
relationship between the inactivation and the voltage varied substantially
for the various mutations. Some mutations manifested positive shifts in
NS1643 Alters Voltage-Sensor Movement 1403the voltage dependence of inactivation, whereas others showed substantial
negative shifts. Indeed, in some mutations, the maximum value of the ratio
(150 ms/Ipeak) was <0.5. To extract a parameter to represent the voltage
dependence of inactivation (with little contamination of deactivation) in a
large number of mutant channels, we used the V0.3 measurement.Two-electrode voltage-clamp in Xenopus oocytes
Macroscopic currents were recorded at room temperature (20–22C) from
Xenopus oocytes bathed in ND96 solution containing NaCl 96 mM, KCl
3 mM, CaCl2 0.5 mM, MgCl2 1 mM, and HEPES 5 mM, titrated to pH
7.4 with NaOH. In experiments using NS1643 (Tocris Bioscience, Minne-
apolis, MN), a 25 mM stock solution of the drug in DMSO (stored at
20C) was diluted in ND96 to a final concentration of 30 mM. This
concentration of NS1643 has been shown to cause near-maximal effects
on wild-type (WT) hERG1 activation in oocytes (14,30,31). Microelec-
trodes were filled with 3 M KCl and had resistances of 0.2–2.0 MU. Voltage
control and data acquisition were achieved using an OC-725C amplifier
(Warner Instruments, Hamden, CT) connected to a Digidata 1440 interface
and using pCLAMP10 software (Molecular Devices, Eugene, OR) run
from a personal computer. Voltage protocols are described in the relevant
text and figure legends. Current signals were acquired at a sampling rate
of 10 kHz (16-bit) and low-pass-filtered at 4 kHz.Voltage-clamp fluorimetry
The methods for fluorimetry have been previously reported in Thouta et al.
(14). L520C was labeled with TMRM (tetramethylrhodamine-5-malei-
mide; Invitrogen, Carlsbad, CA) by bathing oocytes in a depolarizing solu-
tion: KCl 98 mM,MgCl2 1 mM, CaCl2 2 mM, and HEPES 5 mM, titrated to
pH 7.4 with KOH, supplemented with 5 mM TMRM for 30 min at 10C in
the dark. Labeled oocytes were washed and stored in standard ND96
solution in the dark until voltage-clamped using an OC-725C amplifier,
as described above. Fluorimetry was performed simultaneously with
voltage-clamp on a TE2000S inverted microscope (Nikon, Mississauga,
Ontario, Canada) outfitted with an epifluorescence attachment and photo-
multiplier-tube module (Cairn Research, Kent, UK) as described previously
in Thouta et al. (14).
In brief, fluorescence emissions at>565 nm were collected by the photo-
multiplier-tube module via a 0.75 NA 20 objective lens focused on a
TMRM-labeled oocyte excited by light at 5255 45 nm. Fluorescence sig-
nals were sampled at 10 kHz; traces represent an average of 3–15 sweeps
and were filtered offline at 400 Hz. Photobleaching of the fluorophore dur-
ing the activation protocol was corrected for by subtracting the fluorescence
signal recorded at a constant holding potential (130 mV) from the
voltage-dependent test signals. Due to the length of the VCF protocols,
experiments were not paired and recordings were made either in control
ND96 solution or 30 mM NS1643. Conductance-voltage (G-V) curves
were derived by plotting peak tail currents, normalized to the maximum
peak tail current, as a function of the preceding voltage step. Fluores-
cence-voltage (F-V) curves were derived by plotting the amplitude of the
fluorescence deflection (DF), normalized to the maximumDF, as a function
of the voltage-step. Both G-V and F-V curves were fitted with a single
Boltzmann function, as described above. Time-constants for the fluores-
cence deflection (Fon) during depolarization and for the return of fluores-
cence (Foff) at 130 mV after depolarization were obtained by fitting the
relevant fluorescence reports with a single exponential function.FIGURE 2 Impact of substitutions of various amino acids at the L529 site.
Data are recorded in transfected hEK cells. (A–C) Current-voltage relation-
ships for various amino-acid substitutions at the L529 site are compared to
WT. Data under control conditions (C) and in the presence of 10 mM
NS1643 (B). (D)D-slope factors in response to NS1643. Data are presented
as mean5 SE. The V1/2 values and k values for each substitution are shown.
(*) P< 0.05; (**) P< 0.01 by Student’s t-test.N values for L529A, L529M,
and L529I are 5, 5, and 15, respectively. See also Tables 1 and 3.Statistical analysis
STATSVIEW (Abacus Concepts, Berkeley, CA) or SIGMAPLOT, Ver.
11.0 (Systat Software, San Jose, CA) were used to analyze the data. Data
are presented as mean 5 SE. The paired or unpaired Student’s t-test was
used to compare data, with a two-tailed value of P < 0.05 designated asbeing significant. Nonlinear regression was used to fit the envelope of tails
to a power function.RESULTS
L529I decreases the slope of the activation-
voltage relationship in response to NS1643
Fig. 1 shows examples of a family of hERG1 currents eli-
cited by command potentials (illustrated in the inset) before
and after application of NS1643. Data are obtained from
transfected hEK cells. The mean current-voltage relation-
ships of the tail currents are shown in the right-hand panel,
before (solid symbols) and after application of NS1643
(open symbols). NS1643 shifted the V1/2 of activation by
205 2 mV in WT hERG1 without alteration in the slope
of the current-voltage relationship. In the drug-free state,
the V1/2 of activation of L529I hERG1 was 315 3. After
the application of NS1643, the V1/2 values are very similar in
WT (375 3 mV) whereas in L529I it was 345 3 mV
(not significant), but the slope of the current-voltage relation-
ship was significantly and substantially flattened. Mean V1/2
and slope factor data are shown in the right panels of Fig. 1.
Fig. 2 evaluates the impact of substitutions of various
amino acids at the L529 site on the response to NS1643.Biophysical Journal 108(6) 1400–1413
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the mutations at the L529 site, at baseline, did not alter
the slope factor of the current-voltage relationship. Fig. 2
D compares the mean D-change in response to NS1643 of
the slope factors for the various mutations. L529A and
L529M produced less flattening of the slope factors in
response to NS1643 compared to that seen with L529I
(see numerical values in Table 1). For activation, some
substitutions shifted baseline V1/2 to the depolarized poten-
tials compared to WT (L529A, Fig. 2 A), whereas others
shifted V1/2 to the hyperpolarized potentials (L529M and
L529I).
Fig. 3 shows the raw tail current data and mean DZa
(Eq. 2) calculations for current-voltage relationships re-
corded near the threshold potential, comparing WT hERG1
to L529I, before and after NS1643 treatment. In the drug-
free state, the Za values were similar in WT and L529I
hERG1. For WT, the Za values were 4.2 5 0.1 before
and 3.9 5 0.2 after NS1643. For L529I, the Za values
were 4.4 5 0.2 before and 3.3 5 0.3 after NS1643. The
DZa values due to NS1643 were 0.3 5 0.1 for WT
and 1.15 0.2 for L529I (P < 0.05). Compared to L529A
and L529M, only the L529I mutation produced a large
change in DZa after treatment with NS1643. These data sug-
gest that NS1643 significantly alters a voltage-dependent
transition in the pathway to activation in L529I hERG1.
The n values are 5 for WT and 5 for L529I.
To further evaluate the pathway to opening of the activa-
tion gate, the envelope of tails was elicited by the command
potentials shown in Fig. 4. A representative example of the
envelope of tails is shown in Fig. 4 B. The character of acti-
vation gating was analyzed by fitting the activation process
to a power function. In the power function, the exponent, n,TABLE 1 Mean electrophysiological measurements recorded for h
application (10 mM)
k Activation
Baseline NS1643 D P
WT 8 5 0 95 0 15 0 a
L529I 9 5 0 215 1 135 1 a
L529A 10 5 1 135 1 35 1 a
L529M 10 5 1 125 1 35 1 a
K525C 18 5 2 165 2 15 2 NSb,c
L529I/K525C 34 5 5 715 10 385 9 a,b,c,d
K525R 9 5 0 245 4 155 4 a
L529I/ K525R 15 5 1 265 1 115 1 a,b,c
R528C 11 5 1 145 1 35 1 a
L529I/R528C 12 5 1 225 2 105 2 a
I567L 8 5 0 95 0 25 0 a
I567L/L529I 9 5 1 145 1 65 1 a,c
The paired Student’s t-test was used for comparison between baseline and NS164
NS1643 are shown as mean5 SE; n, number of experiments; NS, not signific
aP < 0.05 change compared to baseline.
bP < 0.01 compared to WT.
cP < 0.05 compared with L529I.
dP < 0.05 comparing a double mutation to its individual component mutation o
Biophysical Journal 108(6) 1400–1413was the modeled value. Metrics were compared in WT and
L529I hERG1 records before and after the application of
NS1643. No significant change was noted in the NS1643-
induced change in the kinetics of activation in either WT
or L529I currents (P values given in the Fig. 4).NS1643 binding alters voltage-sensor movement
in L529I mutant channels
To support the notion that NS1643 alters voltage-sensor
transitions before opening of the activation gate, voltage-
clamp fluorimetry experiments were performed to track
the voltage-sensor movement comparing L529I before
and after treatment with NS1643 (Fig. 5). These experi-
ments were performed in Xenopus oocytes where the effect
of NS1643 on L529I mutant channels was qualitatively
similar to that observed in hEK cells (compare Figs. 1
and 5 C). In oocytes, 30 mM NS1643 increased the slope
factor from 8.9 5 0.4 to 12.9 5 1.2 (n ¼ 5; paired
data; P < 0.01) and left-shifted the G-V curve (the V1/2
shifted from 46.4 5 0.7 to 52.0 5 2.0; P < 0.05).
To perform fluorescence measurements of S4 movement,
TMRM is covalently attached to L520C in the S3-S4 linker
as previously shown in Thouta et al. (14), Cheng et al. (30).
Fig. 5, A and B, shows typical ionic current and fluores-
cence data recorded at a range of potentials from
TMRM-labeled L529I L520C channels in the absence
and presence of 30 mM NS1643. Fig. 5 D shows that
NS1643 shifted the V1/2 of ionic current activation
from 42.35 2.0 mV to 50.55 1.7 mV (n ¼ 10; paired
data; P < 0.01) and increased the slope factor, k (i.e.,
reducing the slope), from 13.5 5 0.6 mV to 15.3 5
0.5 mV (P < 0.01).EK cells at room temperature, at baseline, and after NS1643
V1/2 Activation (mV)
n Baseline NS1643 D P n
20 175 2 37 5 3 205 2 a 20
25 315 3 34 5 4 45 4 NSb 25
5 75 5 20 5 3 135 2 a,c 5
5 205 2 425 3.5 225 3 a 5
5 645 7 1275 6 635 10 a,b,c 5
5 635 8 1205 21 575 20 a,b,c 5
5 635 4 1035 3 405 3 a,b,c 5
5 365 4 79 5 4 425 5 a,b,d 5
7 35 1 33 5 4 355 4 a,c 7
9 285 3 59 5 2 315 4 a,b,d 9
5 35 3 29 5 4 265 6 a 5
7 235 2 41 5 4 185 5 a,d 7
3. Otherwise, ANOVA analysis was used. Electrophysiological responses to
ant compared to baseline.
ther than L529I.
FIGURE 3 Activation near threshold. Representative data are recorded in
transfected hEK cells. The family of currents (A and B) and the current-
voltage relationships of tail currents (C and D) elicited by the command
potential (inset, A) are shown for WT in the upper row (A and C) and
L529I (B and D) in the bottom row. Baseline and data after NS1643 are
shown. From a holding potential of 80 mV, voltage steps were applied
at 2–4 mV increments at voltages negative to the threshold potential and
from threshold to values þ16 mV above the threshold values. Data under
control conditions (C) and in the presence of 10 mM NS1643 (B) are
compared. (E) The Za values are calculated and the DZa in response to
NS1643 are compared. n ¼ 5 for WT and n ¼ 5 for L529I. (*) P < 0.05
by Student’s t-test.
FIGURE 4 Time-delay to activation in envelope of tails. Data were re-
corded in transfected hEK cells. The activation of the hERG1 channels at
the V1/2 potential was tested by depolarization of various durations. (A)
Envelope of the tail currents was fitted to a power function with the expo-
nent, n. N values for WT in control and NS1643 are 8, and for L529I n ¼ 8.
Baseline values for n, the exponent in the power model (see Materials and
Methods), is significantly different comparing WT to L529I; however,
NS1643 does not significantly affect the exponent value in either WT or
L529I. (B) Fit to a power function (see Materials and Methods). The fit is
established using nonlinear regression within MATLAB. Mean power func-
tion fits are n ¼ 8 for both WT and L529I.
NS1643 Alters Voltage-Sensor Movement 1405Compared to L529I, the reduced effect of NS1643 in
TMRM-labeled L529I L520C channels appears to be due
to the L520C mutation, because the magnitude of the effect
of NS1643 was similar in L529I L520C channels with and
without TMRM (Table 2). Fig. 5 shows that the V1/2 of
the F-V curve was not significantly changed (P > 0.05)
by drug binding; however, the slope factor of the F-V rela-
tion was significantly increased by NS1643 (from 20.2 5
0.2 mV to 22.9 5 0.5 mV; n ¼ 12 and 13; unpaired data;
P < 0.01). In control experiments, using TMRM-labeled
L520C channels (Fig. 5 F), the V1/2 of ionic current activa-
tion was left-shifted (P < 0.01) from 26.4 5 1.2 mV in
ND96 to 33.0 5 1.9 mV in the presence of NS1643
(n ¼ 8; paired data), similar to the effect observed in WT
channels expressed in mammalian cells (Fig. 1 A). However,
NS1643 had no effect (P > 0.05) on the slope factor of the
L520C G-V curve (11.8 5 0.2 mV to 12.6 5 0.3 mV). In
control fluorescence experiments, NS1643 had no signifi-
cant effect on either V1/2 or k values in L520C channels
(Fig. 5 G and Table 2). These data suggest that NS1643
reduces the voltage-sensitivity of activation (increases the
slope factor) in L529I channels via an effect on voltage-
sensor movement, whereas the shift in the steady-state
voltage dependence appears to result from an effect later
in the activation pathway.
The time-course for the onset of the fluorescence deflec-
tion (Fon) during the pulse was not altered by the presence of
NS1643 in L529I L520C. At þ60 mV, the t-value of Fon
was 54 5 7 ms in control (n ¼ 12) and 52 5 4 ms withNS1643 (n ¼ 13); and at 0 mV, the corresponding values
were 81 5 7 and 60 5 4 ms (P > 0.05). This suggests
that the effects of the drug on the slope of the G-V and
F-V relationships of the L529I L520C construct are unlikely
related to an effect on activation kinetics. Interestingly, the
t-value for the return of fluorescence (Foff) at 130 mV
in L529I L520C channels increased significantly from
118 5 12 ms (n ¼ 12) under control conditions to 217 5
24 ms (n ¼ 13, P < 0.05) in 30 mM NS1643. The influence
of NS1643 on Foff suggests that the drug slows the rate of
voltage-sensor return upon repolarization. These fluores-
cence studies suggest that the presence of NS1643 within
its binding pocket alters activation and deactivation gating
of hERG1 L529I channels by directly modifying voltage-
sensor transitions.Mutations in the S4 helix that alter the
pharmacologic response to NS1643
Tables 3 and 4 show the mean raw data at baseline, after
treatment with NS1643 and the D NS1643-induced changes
in deactivation t values and in the V0.3 inactivation for
inactivation for all of the mutations in the neighborhood
of the S4 helix. The conductance values for each of these
mutations are presented in Table 4. To further explore
whether an interface between NS1643 and charged and un-
charged elements within the S4 could alter the pharmaco-
logic response in the L529I channel, a series of mutations
at sites in the neighborhood of L529 in the S4 helix were
made. The mutations evaluated are shown in Fig. 6 E. WeBiophysical Journal 108(6) 1400–1413
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FIGURE 5 Effects of NS1643 on the fluorescence report of voltage-sensor movement in L529I L520C and L520C channels. (A) Ionic current families
recorded from one Xenopus oocyte expressing hERG L529I L520C mutant in control ND96 solution (C) and with 30 mM NS1643 (B). The cell was
held at 100 mV and 2-s voltage steps were applied in 10-mV steps between 130 and þ50 mV; tail currents were measured at 130 mV. (Arrows)
Zero current level; current traces were not leak-subtracted. (B) Fluorescence signals recorded at different potentials from a TMRM-labeled cell in control
solution (C) and from another cell in the presence of NS1643 (B). (C) G-V curves derived using standard tail current analysis (see Materials and Methods)
from nine oocytes expressing L529I channels under control conditions and with NS1643. (D) G-V curves obtained from 10 TMRM-labeled oocytes express-
ing L529I L520C channels under control conditions and with NS1643. (E) The effects of NS1643 on the F-V curve of L529I L520C channels. For each cell,
the amplitude of the downward fluorescence deflection (DF) at the end of each voltage pulse was normalized to the peak DF. The data represent 12 (control)
and 13 (NS1643) experiments. (F) The G-V relationships obtained from eight TMRM-labeled oocytes expressing L520C channels under control conditions
and with NS1643. (G) F-V relationships of L520C channels under control conditions (n ¼ 12) and with NS1643 (n ¼ 11). Voltage protocols used to collect
data for (B)–(G) were the same as described for A. All data in (C)–(G) are presented as meanR SE. (Solid and dashed lines) Fits to the Boltzmann function
(see Materials and Methods). (*) Statistical significance compared to control data. See text and Table 2 for fit parameters.
1406 Guo et al.found that K525C has no impact on the slope factor of
activation. However, the double mutation, K525C/L529I,
even in the absence of NS1643, produced a very substantial
reduction in the slope factor of activation. When NS1643
was applied to K525C/L529I channels, the slope factor
was dramatically flattened with a slope factor of >70. The
V1/2 was also dramatically shifted to hyperpolarized poten-
tials. In additional experiments, flattening of the slope
factor in response to NS1643 was also more modestly flat-
tened in the K525R mutation. These data indicate that not
only the charge of the amino acid at K525 but also its
size is a determinant of the response to NS1643. The slope
factor of the double mutation K525R/L529I in the drug-
free state mimics the effect of NS1643 in the L529I single
mutant channel. In contrast, mutations at R528 had no
substantial effects. These data point to an important inter-
face of NS1643 with L529 and K525 that could partially
shield this important charged amino acid in the voltage-Biophysical Journal 108(6) 1400–1413sensor. In the reported hERG1 homology models, L529
and I567 are physically close together (18–20), thus we
explored other potential hydrophobic interactions. How-
ever, the double mutation L529I/I567L did not substantially
alter the slope factor of activation seen during NS1643
treatment.MD and structural analysis for L529I mutant
To better understand the effect of the L529I mutation on the
structure of hERG1 channel, we performed all-atom MD
simulations with previously developed models of hERG1
channel in different conformational states. The MD data
shows that the conservative mutation L529I resulted in a
minimal perturbation to the hERG1 homology model global
structure, but caused local changes in the voltage-sensing
domain (VSD). The RMSD analysis from MD simulations
for both model states (i.e., open and closed) shows that
TABLE 2 Summary of mean fit parameters for data collected from Xenopus oocytes, at baseline and after NS1643 application
(30 mM)
k (mV) V1/2 (mV) n
Control NS1643 P Control NS1643 P Control NS1643
GV curves
L529I 8.9 5 0.4 12.95 1.2 a 46.45 0.7 52.05 2.0 b 5 (paired)
L529I L520C 8.2 5 0.3 10.15 0.4 a 37.35 2.1 45.75 2.1 a 9 (paired)
L529I L520C with TMRM 13.55 0.6 15.35 0.5 a 42.352.0 50.55 1.7 a 10 (paired)
L520C with TMRM 11.85 0.2 12.65 0.3 NS 26.45 1.2 33.05 1.9 a 8 (paired)
FV curves
L529I L520C 20.25 0.5 22.95 0.5 a 44.55 2.7 48.95 2.3 NS 12 13
L520C 17.85 0.5 16.15 0.9 NS 24.85 2.1 28.25 2.8 NS 12 11
Data are shown as mean 5 SE; NS, not significant compared to control.
aP < 0.01 compared to control.
bP < 0.05 compared to control.
NS1643 Alters Voltage-Sensor Movement 1407the mutation decreases flexibility of the VSD structure
(Fig. 7 A). For closed and open states, the L529I mutation
also had an effect on the helicity by introducing a kinked
S4 helix (Table S1 and Fig. 7 B). That change affects the
packing of the VSD, and also the structure of helix S3, espe-
cially in the closed state. The persistent contacts of L529 for
WT and I529 in the mutant were analyzed for open and
closed state models. The several salt-bridge interactions
that form spontaneously within the VSD during simulations
were also monitored for both states for WT and mutant. As
expected, the conservative L529I mutation introduced only
minimal perturbations. A complete analysis of the amino-
acid packing is presented in Figs. S3–S9. One interesting
observation is that the L529I substitution tends to affect
stability of the key salt-bridges involving K525 and in
particular, D466-K525. For WT, the distribution of dis-
tances spans to larger values indicating significant flexibilityTABLE 3 Mean electrophysiological measurements recorded for h
application (10 mM)
Deactivation (t, ms)
Baseline NS1643 D/baseline P
WT 1295 13 2645 31 1.05 0.2 a
L529I 1045 10 1895 10 0.85 0.2 a
L529A 565 11 80 5 9 0.45 0.1 a
L529M 3295 62 4035 27 0.25 0.3 NSb
K525C 2135 18 3195 25 0.55 0.2 a,b
L529I/K525C 805 14 2555 19 2.25 0.5 a,c
K525R 1205 12 2235 19 0.95 0.3 a
L529I/ K525R 565 6 1735 27 2.15 0.2 a
R528C 2895 39 3885 56 0.35 0.1 a,b,c
L529I/R528C 895 6 1835 14 1.15 0.2 a,d
I567L 745 16 1605 40 1.15 0.1 a
I567L/L529I 1065 9 2315 25 1.15 0.3 a
The paired Student’s t-test was used in comparison between baseline and NS164
in Materials and Methods. Electrophysiological responses to NS1643 are shown
number of experiments; NS, not significant compared to baseline.
aP < 0.05 change compared to baseline.
bP < 0.01 compared to WT.
cP < 0.05 compared with L529I.
dP < 0.05 comparing a double mutation to its individual component mutation oaround this site. L529I not only shifts the average distance
for this salt-bridge to shorter values, it also eliminates
water-mediated salt-bridging.NS1643 binding sites from docking studies
To evaluate the binding mode of NS1643 to WT and L529I
variants of hERG1, we performed high-precision docking to
MD-refined structures of the WT and mutant forms of the
channel. NS1643 was docked to closed and open state WT
and L529I mutant structures extracted from clustering of
MD trajectories. We considered kinked and straight helical
structures for our docking studies of open and closed states
in the case of mutant. Importantly, MD simulations of WT
do not display any kinked structures for simulations of
open and closed states, while L529I simulations display a
predominantly kinked structure of S4. Three potentialEK cells at room temperature, at baseline, and after NS1643
V0.3 inactivation
n Baseline NS1643 D/baseline P n
9 25 5 4 195 4 65 1 a 6
18 23 5 3 125 4 115 3 a 11
5 18 5 4 125 3 95 5 NS 4
5 28 5 14 355 3 75 12 NS 5
5 33 5 2 245 3 95 3 a 4
8 11 5 3 45 4 75 4 NS 10
4 26 5 2 195 7 85 5 NS 4
5 23 5 4 45 6 195 3 a 4
8 26 5 1 145 2 115 2 a 8
7 11 5 4 95 5 35 2 NS 6
5 26 5 4 205 4 75 4 NS 9
5 17 5 2 45 2 135 2 a 18
3. Otherwise, ANOVA analysis was used. The V0.3 inactivation is described
as mean5 SE. D for deactivation designates Dt (ms)/baseline t (ms); n,
ther than L529I.
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TABLE 4 Meanmaximum channel conductances recorded for
hEK cells at room temperature, at baseline, and after NS1643
application (10 mM)
Conductance (nS)
Baseline NS1643 NS1643/baseline P n
WT 2855 51 3245 59 1.15 0.1 NS 20
L529I 1345 14 1575 16 1.25 0.1 NSa 25
L529A 1825 27 2305 36 1.35 0.1 a 5
L529M 1405 17 1455 15 1.15 0.1 NS 5
K525C 995 20 1155 27 1.25 0.1 NS 5
L529I/K525C 525 12 81 5 16 1.65 0.4 NS a 5
K525R 1795 33 1955 31 1.15 0.1 NS 5
L529I/ K525R 2925 39 3265 45 1.15 0.1 NS 5
R528C 1675 19 2155 38 1.35 0.1 NS 7
L529I/R528C 505 9 97 5 19 1.95 0.3 a,b 9
I567L 1625 48 2155 54 1.35 0.1 b 5
I567L/L529I 1495 31 1575 31 1.15 0.1 NS 7
The paired Student’s t-test was used in comparison between baseline and
NS1643. Otherwise, ANOVA analysis was used. The maximum channel
conductances was calculated as maximum tail currents divided by the
driving forces assuming the reversal potential of 80 mV, shown as
mean5 SE. Statistics P were calculated as NS1643 compared to baseline,
with the paired Student’s t test used; n, number of experiments; NS, not sig-
nificant compared to baseline.
aP < 0.01 compared to WT.
bP < 0.05 change compared to baseline.
FIGURE 6 Molecular site(s) of NS1643 mediated change in voltage-
sensormovement.Data are recorded in transfected hEKcells.Representative
examples of current-voltage relationships (A, K525C, C; (B), L529I/
K525C,B; and (C), L529I/K525C after addition of 10 mM NS1643,,).
(D) Average Boltzmann fitting results of K525C, L529I/K525C, and
L529I/K525C in 10 mM NS1643 yielded V1/2 values (mV) of 665 3.8,
56.8 5 5, and 120 5 21; respectively, and k values (mV) of 16.4 5
1.5, 37.45 3.2, and 71.45 10.2, respectively (n ¼ 10, 10, and 5, respec-
tively). (E) The slope factors of mutations at baseline and with 10 mM
NS1643. N values for each group are shown above respective bars. (a)
P < 0.01 compared to WT. (b) P < 0.01 versus L529I. (g) P < 0.01 versus
its single partnermutation. (*)P< 0.01 versus the samemutation at baseline.
(d) P < 0.01 in the presence of NS1643 compared to L529I. The paired
Student’s t-test was used in comparison between baseline and NS1643.
Otherwise, analysis of variance (ANOVA) was used. See also Tables 1 and
3. For paired mutation groups, n ¼ 20, 25, 5, 5, 5, 5, 7, 9, 5, and 7.
1408 Guo et al.binding sites in the vicinity of L529 (interface between
helices S1, S2, S3, S4, and S5 of the adjacent subunit)
were explored in the BS1, BS2, and BS3 sites (Figs. S10,
S11, and S12). All of them have similar binding affinities
(see Table S2), rendering identification of a unique binding
site difficult.
It is quite possible that the NS1643 drug binds to all these
binding sites simultaneously with similar affinity, and that
the L529I mutation is affecting the binding not through a
direct interaction with the drug but by inducing a structural
change that affects the different binding sites to differing ex-
tents. It is also worth noting that additional work extending
simulations other than docking studies will help to resolve
specificity for each of the sites better. The BS2 site was
previously described as IC2 (18), and was successfully
used recently for the rational design, chemical synthesis,
and experimental evaluation of new hERG1 activators.
For the purpose of this study, we focused on the BS1 site
(see Fig. 8), where the drug is in proximity with L529 and
K525, the two key residues identified experimentally. The
drug interacts directly with K525 in the open state. This
interaction is completely obliterated in the closed state,
where K525 is salt-bridging to D466. Although it is possible
that this salt-bridge could be affected by the drug binding to
the closed state, further studies such as MD including the
drug are necessary to prove that. For both the open and
closed cases, the docking shows that the mutant binding
site is rearranged when the S4 helix is kinked and the bind-
ing affinity for NS1643 is a little higher compared to the
straight-less-curved S4 helix in WT (see Table S2).Biophysical Journal 108(6) 1400–1413DISCUSSION
The main innovative findings of this study are that various
substitutions at the L529 residue can shift the baseline
V1/2 of activation to the left (L529I; 31 5 3 mV) or to
the right (L529A; 7 5 5 mV) compared to WT (17 5
2 mV), but after treatment with NS1643, all substitutions
at the L529 site flatten the IV curve (Tables 1 and 3). More-
over, the extent of flattening of the slope factor by NS1643
for L529I was significantly greater than seen with the other
A B
FIGURE 7 Summary of MD simulations for closed and open state homology models of WT and L529I hERG1. (A) RMSD for all subunits, showing the
backbone fluctuations for open and closed states of WT hERG1 (top) and L529I (bottom). WT is depicted in open state (black) and closed state (blue), L529I
is depicted in open state (gray), and closed state (light blue). (B) Structure comparison between the S4 helix (in red) of WT (top) and L529I (bottom) for
closed and open states of hERG1. Only one subunit is shown, and the S1 segment is omitted for clarity. To see this figure in color, go online.
NS1643 Alters Voltage-Sensor Movement 1409substitutions (Table 1). In WT channels, we propose that
NS1643 is coordinated in a putative binding site in proximity
to L529 and K525 (BS1, Fig. 8). We propose that
binding of NS1643 to this putative binding site changes its
topology destabilizing a salt-bridge between K525 and
D466, which consequently destabilizes the resting state of
the voltage sensor. In the baseline drug-free state, the
L529I mutation was not associated with a flatten-the-slope
factor (9 5 0.4 mV with L529I compared to 8 5 0.2 mV
with WT), but in the presence of NS1643, the slope
factor for activation of L529I is significantly flattened
(225 1.5 mV for L529I versus 95 0.3 mV for WT). More-
over, when NS1643 was applied to K525C/L529I channels,
the slope factor was very dramatically flattened and shifted
to hyperpolarized potentials. NS1643 shifts the V1/2 of acti-
vation of both K525C and K525C/L529I to hyperpolarized
potentials (131 5 4.4 mV for K525C and 120.4 5
21.3 mV for K525C/L529I), but the response (D) of the
slope factor to NS1643 for K525C/L529I was þ38 5
9.1 vs.15 2.3 mV for K525C, P< 0.001). For the double
mutation I567L/L529I, the baseline value (95 1was similar
to L529I (9 5 0), but after NS1643 the slope factor of
the double mutation (14 5 1) was less than that seen with
L529I (21 5 1; P < 0.05). These data suggest that the
I567L mutation may modify the spatial interaction of
NS1643 with L529. The shallow slope of the G-V relation-
ship is indicative of reduced voltage sensitivity, and this issupported by our limiting slope analysis, which shows
thatDZawas reduced by NS1643 in L529I, but notWT chan-
nels. Modeling studies of ionic current data suggest that the
activation pathway in hERG1 channels involves progression
through two voltage-dependent steps separated by a voltage-
independent step that becomes rate-limiting at strongly de-
polarized voltages (10,33). This scheme was subsequently
modified, based on gating current data, to detail two
consecutive and independent voltage-sensitive transitions
within each a-subunit of the channel that occur before the
voltage-independent step (12). Despite these studies, under-
standing of hERG1 activation gating lacks the depth of that
for Shaker channels and this can challenge mechanistic
interpretation of data.
A power analysis of the envelope of tails data indicates
that the exponent of the power function, n, was significantly
changed in the baseline condition in L529I compared toWT.
These data indicate that the L529I mutation at baseline
appears to alter the extent of the cooperativity between sub-
units in the pathway toward activation. However, NS1643
did not significantly alter the exponent values in either
WT or L529I. So, while there may be evidence for a
change in cooperativity, it does not appear to explain the
difference in the slope factor observed during NS1643
when comparing WT to L529I. These data are consis-
tent with the idea that NS1643 alters movements of the
voltage-sensor before opening of the activation gate. TheBiophysical Journal 108(6) 1400–1413
AB
FIGURE 8 NS1643 binding site in the vicinity of L529 and K525 (BS1) from docking to closed and open state hERG1 homology models. (A) Docking of
NS1643 to open (right, gray) and closed (left, blue) homology models states of WTand L529I hERG1. The best docked structures to the BS1 binding sites are
shown. (B) Diagram for NS1643 interactions in the BS1 binding sites for open (right) and closed (left) states. Residues are represented as colored spheres with
the residue name and number; the color indicates the residue type. Interactions with the protein are marked with lines between the ligand atoms and residues.
The protein pocket is displayed with a line, colored with the color of the nearest protein residue. Gaps in the line show the accessibility of the binding pocket.
The cutoff used to display the interactions was 4.5 A˚. To see this figure in color, go online.
1410 Guo et al.envelope of tails does not interrogate the movements of the
voltage-sensor; instead, it assesses kinetics of opening of the
activation gate. To assess movements of the voltage-sensor,
a fluorimetric reporter of movements of the S4 was used. In
an accompanying article, a kinetic model is used to eluci-
date state-dependent transitions on the path toward opening
of the activation gate (34).
The combined approach of analyzing ionic currents, fluo-
rimetric measurement of voltage-sensor movement, and
molecular dynamic simulations, is the strength of this study.
Our data indicates that NS1643 alters the voltage-sensitivity
of movements of the voltage-sensor or alters the potential
cooperative movements of the voltage-sensor that precede
the activation gate opening. It appears that NS1643 may
partially shield the K525 residue or alter the allosteric ter-
tiary structure of the voltage sensor during its movements.
Our examination of the response of the S4 to quite conser-Biophysical Journal 108(6) 1400–1413vative substitutions, K525R and L529I, suggests that both
size and tertiary structure as well as charge/or hydrophobic-
ity influence the response to NS1643. It appears that it may
not just be shielding of charged residues but that NS1643
may produce an allosteric tertiary structure change of the
voltage-sensor during its transitions toward opening of the
activation gate. Interestingly, a 2013 study showed func-
tional interactions of K525 with a putative gating-charge
transfer center formed by F463 and D466 that stabilize the
closed state (30). In Shaker, the highly conserved phenylal-
anine (F290) forms a hydrophobic plug that acts to shuttle
S4 positive charges across the membrane during gating.
Therefore, one possibility is that NS1643 interferes with
the interactions of K525 with the gating-charge transfer
center to destabilize the resting state of the voltage sensor
and reduce charge movement upon activation. Consistent
with this, parallel recording of fluorescence signals, which
NS1643 Alters Voltage-Sensor Movement 1411reflect movement of the voltage sensor, confirm that
NS1643 alters movement of the voltage sensor in L529I
channels.Fluorimetry reporter of movement of the S4
voltage sensor
Voltage-clamp fluorimetry has been used widely to
report upon conformational dynamics of voltage sensors
in numerous channels (31,35–43) including hERG1
(14,29,36–39,44). Fluorophores attached at L520C in the
S3-S4 linker of hERG1 channels report slow depolariza-
tion-induced environmental changes that mirror the time
course and voltage dependence of ionic current. Consistent
with the notion that fluorophores labeling the hERG1S3-S4
linker report specifically upon voltage-sensor movement, it
was reported in 2012 that perturbations altering pore opening
did not affect the fluorescence signal (35). Thus, it appears
that fluorophores attached in the S3-S4 linker of hERG1 track
the bulk of the charge movement that is relatively slow, a
conclusion that is supported by gating current measurements
(12,35). Here, we report the effects of NS1643 binding on
the dynamics of voltage-sensor movement in hERG1 L529I
channels. These data suggest that NS1643 reduces the
voltage sensitivity of voltage-sensor movement and slows
the return of the voltage sensor to its resting configuration
upon repolarization. These data suggest that the presence
of NS1643 within its binding pocket alters activation and
deactivation gating of hERG1 channels by directly modi-
fying voltage-sensor transitions.MD simulations and binding of NS1643: L529I
induced structural rearrangements in the
transmembrane S4 domain
The MD data shows that in both closed and open states of
hERG1, the L529I mutation increases rigidity of the local
elements and affects helicity by introducing a kinked S4
helix. That change affects the packing of the VSD and the
structures of helix S2 and S3, especially in the closed state
(Fig. 7). In addition to this, docking studies suggest a poten-
tial binding site in the vicinity of L529 and K525 (BS1,
Fig. 8; and see Figs. S11 and S12). Taking these results
together, we suggest that the L529 residue is a key element
in determining the VSD local structure and packing, and it is
involved in NS1643 binding not through direct interactions
with the drug but by regulating the appropriate structure of
the binding sites. Additionally, the K525 residue interacts
directly with the drug in the open state, probably stabilizing
it. This interaction is missing in a closed channel, illumi-
nating significance of the K525-NS1643 interaction for sta-
bilization of the open state. One hypothesis suggested here
is that the drug could also affect this salt-bridge interaction,
destabilizing the closed state and thus favoring the channel
opening. This not only provides a tentative explanation forobserved experimental results, but also testable hypotheses
for a kinetic modeling. In the accompanying article (34),
we performed kinetic modeling of currents using experi-
mental data to test different gating schemes in the presence
of NS1643 and to connect to atomistic simulations. Kinetic
models allow isolation of the gating transition explicitly
affected by the presence of NS1643.Amino acids in the transmembrane S4 domain
are candidates for an interaction site that
mediates the hERG1 opener pharmacologic
activity of NS1643
In our previous work, we suggested the presence of multi-
ple potential binding sites for NS1643 in hERG1 (18). One
potentially important binding domain of hERG1 may be
within the S4 in the neighborhood of L529. Mutations pro-
ducing some of the greatest impact on the pharmacologic
response to NS1643 exist in the S4 domain. For example,
the leftward shift in activation by NS1643 in the T526M
channel was 59 5 9 mV compared to 18 5 3 mV in
WT hERG1. The mutation of L564A in the S4 abrogates
the ability of NS1643 to increase the magnitude of the
tail current. NS1643 abrogates the inward conductance
seen in a mutation located at the cytosolic junction of the
S4 segment, D540K (18). These data suggested that
NS1643 prevented the inward movement of the S4 segment
of the D540K channel. The results of this study provide
further evidence suggesting that NS1643 interacts to alter
function of the S4 and its movements before opening of
the activation gate. The fluorescence studies also suggest
that presence of NS1643 within its binding pocket alters
activation and deactivation gating of hERG1 channels by
modifying voltage-sensor transitions. Finally, amino acids
L529 and K525 of hERG1 are candidates for an interaction
site that mediates the hERG1 opener pharmacologic activ-
ity of NS1643. The presence of NS1643 in this putative
binding site appears to alter activation and deactivation
gating of hERG1 channels by modifying voltage-sensor
transitions.CONCLUSIONS
A potential hypothesis that explains coupling between drug
binding and channel gating that is consistent with our data
from a multitude of methods is schematically summarized
in Fig. 9. In this hypothetical model, the strength of the
salt-bridge between D466 and K525 is diminished as the
hydrophobic molecule, NS1643, interdigitates with this
domain in the WT channel. The presence of NS1643 in
this site would diminish the latching effect of the salt-bridge
in the closed state and allow the electromotive force to
more easily move the voltage sensor, while stabilizing the
open state through a direct interaction with K525. We recog-
nize that this is a simplistic representation of a complexBiophysical Journal 108(6) 1400–1413
FIGURE 9 Cartoon representation of how the interaction of NS1643 and key residues can influence voltage-sensor movement in open and closed states
in WT and L529I. The structure and packing of the voltage-sensing domain (VSD) is affected by the L529I mutation and it is shown in different colors for
WT (green) and L529I (blue). The interaction with NS1643 (magenta star) is shown for only one VSD subunit in the respective darker color. In this model,
the strength of the salt-bridge between D466 and K525 present in the closed state (charges highlighted in red) is diminished as the hydrophobic molecule,
NS1643, interdigitates with this domain (charges highlighted in orange). In the open state, the drug is directly interacting with K525 (interaction highlighted
in yellow) probably stabilizing the open state over the closed. To see this figure in color, go online.
1412 Guo et al.conformational change occurring in the voltage-sensor
movement before the opening of the activation gate. To bet-
ter understand the effect of the mutation and the NS1643
drug in terms of a kinetic mechanism, Markov models
were used to describe the gating kinetics in an accompa-
nying study. Consistent with what is proposed here, the
modeling of ionic current data shows that the drug is
affecting the early transitions to the open state and captures
the dramatic perturbation to these early transitions caused
by the L529I mutation (Perissinotti et al. (34)).SUPPORTING MATERIAL
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